Tuberculosis Vaccines

"Tuberculosis Vaccines" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Vaccines or candidate vaccines used to prevent or treat TUBERCULOSIS.

Descriptor ID

D032581

MeSH Number(s)

D20.215.894.135.825

Concept/Terms

Tuberculosis Vaccines

Below are MeSH descriptors whose meaning is more general than "Tuberculosis Vaccines".

Chemicals and Drugs [D]
Complex Mixtures [D20]
Biological Agents [D20.215]
Vaccines [D20.215.894]
Bacterial Vaccines [D20.215.894.135]
Tuberculosis Vaccines [D20.215.894.135.825]

Below are MeSH descriptors whose meaning is more specific than "Tuberculosis Vaccines".

Tuberculosis Vaccines
BCG Vaccine

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Tuberculosis Vaccines" by people in Harvard Catalyst Profiles by year, and whether "Tuberculosis Vaccines" was a major or minor topic of these publication.

Bar chart showing 34 publications over 16 distinct years, with a maximum of 3 publications in 2008 and 2010 and 2014 and 2016 and 2018 and 2019

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2004	1	0	1
2005	0	2	2
2006	1	1	2
2007	2	0	2
2008	1	2	3
2009	2	0	2
2010	3	0	3
2011	1	0	1
2012	2	0	2
2013	1	0	1
2014	2	1	3
2016	1	2	3
2017	1	0	1
2018	2	1	3
2019	2	1	3
2020	2	0	2

Below are the most recent publications written about "Tuberculosis Vaccines" by people in Profiles.

Bloom BR. The search for better vaccines against TB. BMJ. 2020 01 15; 368:m92.

View in: PubMed
Tanner R, Satti I, Harris SA, O'Shea MK, Cizmeci D, O'Connor D, Chomka A, Matsumiya M, Wittenberg R, Minassian AM, Meyer J, Fletcher HA, McShane H. Tools for Assessing the Protective Efficacy of TB Vaccines in Humans: in vitro Mycobacterial Growth Inhibition Predicts Outcome of in vivo Mycobacterial Infection. Front Immunol. 2019; 10:2983.

View in: PubMed
Reuter A, Hughes J, Furin J. Challenges and controversies in childhood tuberculosis. Lancet. 2019 Sep 14; 394(10202):967-978.

View in: PubMed
Kawahara JY, Irvine EB, Alter G. A Case for Antibodies as Mechanistic Correlates of Immunity in Tuberculosis. Front Immunol. 2019; 10:996.

View in: PubMed
Joosten SA, Ottenhoff THM, Lewinsohn DM, Hoft DF, Moody DB, Seshadri C. Harnessing donor unrestricted T-cells for new vaccines against tuberculosis. Vaccine. 2019 05 21; 37(23):3022-3030.

View in: PubMed
Cadena AM, Hopkins FF, Maiello P, Carey AF, Wong EA, Martin CJ, Gideon HP, DiFazio RM, Andersen P, Lin PL, Fortune SM, Flynn JL. Concurrent infection with Mycobacterium tuberculosis confers robust protection against secondary infection in macaques. PLoS Pathog. 2018 10; 14(10):e1007305.

View in: PubMed
Li H, Javid B. Antibodies and tuberculosis: finally coming of age? Nat Rev Immunol. 2018 09; 18(9):591-596.

View in: PubMed
Moradi J, Izad M, Tabrizi M, Mosavari N, Esmaeili B, Feizabadi MM. Specific immune responses induced by multi-epitope DNA derived from Mycobacterium tuberculosis DosR antigens. Acta Microbiol Immunol Hung. 2018 Jun 01; 65(2):193-209.

View in: PubMed
Salehi M, Abdizadeh R, Pourgheysari B, Zamanzad B, Soltani A, Gholipour A, Heidari R. Evaluation of cellular immunogenicity of recombinant cytochrome p450 cyp141 protein of Mycobacterium tuberculosis in human and mouse model. Biologicals. 2018 Mar; 52:25-29.

View in: PubMed
Nduba V, Van't Hoog AH, Mitchell EMH, Borgdorff M, Laserson KF. Incidence of Active Tuberculosis and Cohort Retention Among Adolescents in Western Kenya. Pediatr Infect Dis J. 2018 Jan; 37(1):10-15.

View in: PubMed

Related Networks

People

Explore

Similar Concepts

Top Journals

Vaccine
J Immunol
PLoS Pathog
Tuberculosis (Edinb)
Infect Immun
Proc Natl Acad Sci U S A
Front Immunol
Clin Vaccine Immunol
Pediatr Infect Dis J
Nat Commun